Original Article
Transplantation of Thymus Tissue in Complete DiGeorge Syndrome
N Engl J Med 1999; 341:1180-1189October 14, 1999DOI: 10.1056/NEJM199910143411603
- Abstract
Background
The DiGeorge syndrome is a congenital disorder that affects the heart, parathyroid glands, and thymus. In complete DiGeorge syndrome, patients have severely reduced T-cell function.
Methods
We treated five infants (age, one to four months) with complete DiGeorge syndrome by transplantation of cultured postnatal thymus tissue. Follow-up evaluations included immune phenotyping and proliferative studies of peripheral-blood mononuclear cells plus biopsy of the thymus allograft. Thymic production of new T cells was assessed in peripheral blood by tests for T-cell–receptor recombination excision circles, which are formed from excised DNA during the rearrangement of T-cell–receptor genes.
Results
After the transplantation of thymus tissue, T-cell proliferative responses to mitogens developed in four of the five patients. Two of the patients survived with restoration of immune function; three patients died from infection or abnormalities unrelated to transplantation. Biopsies of grafted thymus in the surviving patients showed normal morphologic features and active T-cell production. In three patients, donor T cells could be detected about four weeks after transplantation, although there was no evidence of graft-versus-host disease on biopsy or at autopsy. In one patient, the T-cell development within the graft was demonstrated to accompany the appearance of recently developed T cells in the periphery and coincided with the onset of normal T-cell function. In one patient, there was evidence of thymus function and CD45RA+CD62L+ T cells more than five years after transplantation.
Conclusions
In some infants with profound immunodeficiency and complete DiGeorge syndrome, the transplantation of thymus tissue can restore normal immune function. Early thymus transplantation — before the development of infectious complications — may promote successful immune reconstitution.
Media in This Article
Figure 2
Biopsy Evaluation of the Thymus Graft in Patient 5.Figure 1
Proliferative Function of T Cells in Patient 5 and Levels of T-Cell–Receptor Recombination Excision Circles (TRECs) in Patients 1 and 5.Article Activity
- Article
The DiGeorge syndrome is a congenital malformation that affects the development of the third and fourth pharyngeal pouches and is associated with a deficiency of T cells.1-3 Many patients with the DiGeorge syndrome are hemizygous for 22q114,5; in rare instances, patients are hemizygous for 10p13.6 Deletion in the UFD1L gene at 22q11 has been described.7 The term complete DiGeorge syndrome is used to describe patients with the syndrome who have profound T-cell deficiency.8-12
Several therapies have been used to treat immunodeficiency associated with the DiGeorge syndrome. In two patients, HLA-identical bone marrow transplantation successfully restored T-cell function by adoptive transfer of mature T cells.13,14 Immune reconstitution was reported after transplantation of peripheral-blood mononuclear cells (PBMCs) in one patient.15 In a few cases, transplantation of fetal thymus was followed by immune reconstitution.16-19 However, some of those patients had partial DiGeorge syndrome with detectable T-cell function before transplantation and might have improved without therapy.11,19 Most published trials of postnatal thymus transplantation have been unsuccessful.20-22 Transplantation of bone marrow stem cells has not been successful.12
We report our experience with a series of five infants with complete DiGeorge syndrome who were treated with allogeneic, cultured, postnatal thymus tissue. We hypothesized that host T cells would develop in the donor thymus allograft and would lead to reconstitution of immune function. In the last patient in our series (and in the first patient, with the use of cryopreserved samples), we also tested the hypothesis that markers of newly formed naive T cells would appear only after thymus transplantation and would correlate with the development of T-cell proliferative function.
Methods
Thymus Transplantation
We obtained discarded thymus tissue from infants 2 to 35 days old who were undergoing corrective heart surgery after we received informed consent from the donors' parents. Down's syndrome was a criterion for exclusion of donors. Preparation of the thymus tissue for transplantation has been described elsewhere.23 In Patient 5, a Stadie–Riggs hand microtome (Thomas Scientific, Swedesboro, N.J.) was used to slice the thymus tissue.24 The slices of thymus tissue were inserted into the quadriceps bilaterally in an open procedure in the operating room.23,25
Immune Testing and Determination of the T-Cell–Receptor Repertoire
We evaluated immune function through standard procedures,26 including flow cytometry and measurement of the incorporation of [3H]thymidine after stimulation of PBMCs (cultures of 105 cells) with phytohemagglutinin and concanavalin A. For studies of flow cytometry, we used murine monoclonal antibodies to CD3, CD4, CD8, CD19, CD20, and CD16 (AMAC, Westbrook, Me.; Coulter, Hialeah, Fla.; Dako, Carpinteria, Calif.; and Becton Dickinson, Mountain View, Calif.). We performed HLA typing using serologic27 and molecular28 techniques. Additional murine monoclonal antibodies were used to characterize the T-cell receptor Vβ (TCRBV) repertoire in Patients 3 and 5 (Coulter; Endogen, Woburn, Mass.; and PharMingen, San Diego, Calif.).
Immunoperoxidase Staining of Frozen and Formalin-Fixed Sections
Four-micrometer frozen sections underwent reaction with antibodies using an avidin–biotin–peroxidase complex technique (Vector Laboratories, Burlingame, Calif.).23 Antibodies directed against thymic-epithelium (TE) antigens included cytokeratin; TE3, expressed on cortical epithelium; TE4, on subcapsular cortical and medullary epithelium; and TE16, on Hassall's corpuscles (clusters of terminally differentiated thymic epithelial cells, which are characteristic of normal thymic medulla). Additional antibodies used in this study on paraffin-embedded tissue included KP-1 (CD-68), which is reactive with macrophages, and S-100, which is reactive with dendritic cells (both from Dako).
Quantification of the Output of the Thymus
We quantified the output of the thymus by measuring the excisional DNA products of T-cell–receptor gene rearrangements (T-cell–receptor recombination excision circles [TRECs]),29 which exist as episomes in T cells and can be detected by the polymerase chain reaction. We performed the assay for signal-joint TRECs29 on PBMCs separated into CD4+ and CD8+ cells, using magnetic microbeads (MACS, Milteny Biotec, Auburn, Calif.). The median numbers of TRECs in four cord-blood samples were 9584 per 100,000 CD4+ cells (range, 9257 to 16,948) and 9729 per 100,000 CD8+ cells (range, 8244 to 14,998). The median values in two normal infants, each studied three times between birth and six months of age, were 10,360 per 100,000 CD4+ cells (range, 7520 to 10,722) and 10,663 per 100,000 CD8+ cells (range, 8026 to 10,997). In nine normal children between 1.9 and 7.4 years of age, the median numbers of TRECs were 11,170 per 100,000 CD4+ cells (range, 7800 to 14,473) and 8413 per 100,000 CD8+ cells (range, 5887 to 13,961).
Results
Patient 1
Patient 1, whose initial course after transplantation on day 90 of life has been reported previously,23,30 presented with no circulating T cells and no T-cell proliferative responses to mitogens (this patient was described as Patient 4 in a previous study12) (Table 1Table 1
Clinical Features of Five Patients with the DiGeorge Syndrome Who Underwent Thymus-Tissue Transplantation.). Within the first month after transplantation of a cultured postnatal thymus allograft from an unmatched male donor into this infant girl, an oligoclonal population of T cells developed that did not proliferate in response to stimulation with mitogens.23,30 On day 17 after transplantation, these CD3+ T cells (2024 per cubic millimeter) were shown to be female by fluorescence in situ hybridization of 101 sorted T cells. Thus, these T cells were not derived from the allograft.An evaluation of an allograft biopsy at three months with the use of HLA monoclonal antibodies revealed host thymopoiesis (T-cell development in the thymus) within donor-thymus epithelium.23,30 In the patient, robust T-cell proliferative responses to mitogens developed,23 and a normal TCRBV repertoire30 developed approximately seven months after transplantation of the thymus. In mixed-lymphocyte reaction, the patient's T cells were unresponsive to the donor's PBMCs.23 B-cell antibody responses to immunization with tetanus toxoid and pneumococcal vaccine were normal.23 Five years later (two years after the initial report),23 the patient had normal responses to mitogens, CD3 stimulation, and mixed-lymphocyte culture (Table 2Table 2
Immunologic Evaluation of Patient 1, 5.5 Years after Thymic Transplantation.), had normal proliferative and antibody responses to tetanus toxoid, and was a normal child.Patient 2
Patient 2 was born with multiple anomalies of CHARGE association (coloboma, heart disease, atresia choanae, retarded growth and development, genital hypoplasia, and ear abnormalities, deafness, or both) (this patient was previously described as Patient 512 and as Patient 133).34-36 This boy had profound immunodeficiency with no T cells detectable by flow cytometry and no proliferative responses to mitogens in PBMCs before transplantation on day 96 of life. On day 49 after the patient underwent transplantation with a cultured postnatal thymus allograft from a haploidentical female donor, the peripheral-blood T-cell proliferative response to phytohemagglutinin was more than 200,000 counts per minute (cpm). This response fell by day 64 after transplantation, probably as a result of steroid therapy that was given after an intracranial hemorrhage. Because of the patient's unexpected death on day 66 after transplantation, there was no opportunity to immunize the patient and assess antigen-specific responses. Phytohemagglutinin-stimulated PBMCs obtained on day 64 after transplantation, two days before the baby's death, were analyzed by fluorescence in situ hybridization for X chromosome markers. The analysis showed 15 percent XY (host) and 85 percent XX (thymus-donor) cells. A polymerase-chain-reaction test for HLA-DR that was performed with an aliquot of these cells also revealed the presence of donor HLA-DR alleles. Thus, this patient had evidence of large numbers of engrafted donor T cells.
An autopsy was performed. No evidence of graft-versus-host disease was found. No native thymus tissue was found despite careful gross and microscopical evaluation. Cytokeratin-positive material was detected in the right and left quadriceps, showing the presence of abundant donor-thymus epithelium (data not shown). One Hassall's corpuscle was identified. No immature, cortical thymocytes were detected in the graft, possibly because of the steroid treatment that was given for 48 hours before the boy's death.
Patient 3
Patient 3 was born with multiple anomalies (Table 1), no circulating T cells, and an absence of PBMC proliferative responses to mitogens. On day 51 of life, the boy was treated with a cultured postnatal thymus allograft from a male donor matched for HLA-DR15. On day 28 after transplantation, the patient had a proliferative response to phytohemagglutinin of 139,503 cpm. Because respiratory failure developed on day 35 after transplantation, the patient was treated with high doses of steroids (40 mg per kilogram of body weight of methylprednisolone sodium succinate [Solu-Medrol]) per day for three days. The number of circulating T cells decreased to 153 per cubic millimeter on day 45 after transplantation and remained below 250 per cubic millimeter in the eight samples tested subsequently. The level of proliferative responses to mitogens decreased to one to four times the base-line level (in four tests). Antigen-specific T-cell responses were not tested. The circulating T cells obtained on day 119 after transplantation were examined by fluorescence in situ hybridization. All cells were male, which ruled out maternal engraftment; they consisted of 90 percent 22q11 hemizygous cells (from the host) and 10 percent 22q11 normal cells (from the donor).
The patient died of respiratory failure on day 130 after transplantation. An autopsy revealed an absence of native thymus, thyroid, and parathyroids, a finding that confirmed the diagnosis of complete DiGeorge syndrome. Histologic evaluation revealed no evidence of graft-versus-host disease. Evaluation of the thymus allograft showed no evidence of thymopoiesis. In addition, antibodies that are usually specific for Hassall's corpuscles reacted with all epithelium (data not shown). The same pattern of reactivity was also found for antibodies that are usually specific for cortical (TE3) or medullary (TE4) epithelium. The very high dose of steroids given to this patient may have contributed to the abnormal appearance of the allograft.
Patient 4
At birth, Patient 4 was found by flow cytometry to have no CD3+ T cells and to have 576 natural killer cells per cubic millimeter and 2215 B cells per cubic millimeter. The PBMCs did not proliferate in response to mitogens. Other findings are described in Table 1. A cytomegalovirus infection developed in the patient and led to dependence on a ventilator. At 127 days of life, the girl received an unmatched thymus transplant. A small number of T cells (47 per cubic millimeter and 22 per cubic millimeter) were detected eight days and one month after transplantation, respectively. Two additional tests revealed no T cells. Because of the lack of T cells, the proliferative function of PBMCs was not assessed. The patient died of sepsis and respiratory failure 45 days after transplantation, at 5.7 months of age. Permission for autopsy was denied.
Patient 5
Patient 5 had multiple anomalies characteristic of CHARGE association (Table 1) in addition to characteristics of complete DiGeorge syndrome (Table 3Table 3
Immune Function of Patient 5.). T-cell function developed steadily in this infant boy after he received postnatal cultured thymus tissue from a haploidentical female donor on day 63 of life (Table 3 and Figure 1AFigure 1Proliferative Function of T Cells in Patient 5 and Levels of T-Cell–Receptor Recombination Excision Circles (TRECs) in Patients 1 and 5.). An increase in CD3+ CD45RA+CD62L+ T cells, indicating cells recently formed in the thymus, was noted beginning one month after transplantation (Table 3). Computed tomography of the chest was performed with contrast three months after transplantation, when T-cell proliferative function had become robust (to determine whether the native thymus had become enlarged), but it showed no evidence of a native thymus. At four and six months after transplantation, the patient had excellent T-cell proliferative responses to allogeneic cells and tetanus toxoid (after one immunization) (data not shown). Fluorescence in situ hybridization at four months, with the use of peripheral blood that had been sorted to include only T cells that were proliferating in response to phytohemagglutinin, showed that all T cells were male (host cells).A biopsy of the thymus allograft performed 10 weeks after transplantation showed a clear distinction between cortex and medulla (Figure 2AFigure 2
Biopsy Evaluation of the Thymus Graft in Patient 5.). Immunohistochemical analysis showed the cortical areas to be full of immature CD1a+ thymocytes (Figure 2B). The Hassall's corpuscles in the medulla were normal, a finding consistent with good thymic function (Figure 2C and Figure 2D). In contrast to the findings in Patient 3, the TE16 antibody reacted specifically with Hassall's corpuscles (Figure 2D), as in a normal thymus, but not with other keratin-positive epithelium (Figure 2C). KP-1–positive cells resembling macrophages (Figure 2E) and S-100+ dendritic cells (Figure 2F) were present primarily in the medulla, as is found in the normal thymus.TREC Analyses
For Patient 1, evaluations of TRECs were done on cryopreserved PBMCs from day 45 and month 26 after transplantation and on fresh samples from 5.5 and 5.8 years after transplantation (Figure 1B). TRECs were undetectable in the initial sample but were present at approximately one third of normal levels 26 months and 5.5 and 5.8 years after transplantation. For Patient 5, TRECs were undetectable before transplantation and increased in parallel with the increase in the numbers of CD45RA+CD62L+ T cells and in T-cell function (Table 3 and Figure 1).
Estimation of Donor T-Cell Content in Thymus Grafts
Deoxyguanosine was used in the culture medium to deplete donor thymocytes in the thymus allografts.37,38 To obtain an estimate of the number of donor thymocytes that remained in the thymus allografts, we cultured three thymuses with deoxyguanosine for two weeks. At the end of the culture period, the tissue was mechanically dissociated and viable thymocytes counted by flow cytometry. We found 0.5×106 to 1.0×106 thymocytes per gram of thymic tissue (weighed on the day of donation). Using the higher estimates and extrapolating to the size of the thymus grafts used in our patients, we concluded that each of our five patients received approximately 0.6×106 to 4.0×106 thymocytes per kilogram with their transplants. On the basis of this calculation, Patient 2, in whom predominantly donor T cells developed, received 8×105 thymocytes per kilogram.
Discussion
The five patients we describe presented with profound cellular immunodeficiency and were classified as having the complete form of the DiGeorge syndrome.12 Two patients (Patients 2 and 5) also had features consistent with the CHARGE association, a rare combination that has been reported previously.8,12,33,36 All five patients had few or no detectable circulating T cells (indicated by the expression of CD3). PBMCs did not proliferate in response to mitogens. In Patients 3, 4, and 5, PBMCs stimulated with interleukin-2 produced vigorous proliferation, presumably due to the proliferation of natural killer cells. Only two of five patients were hemizygous for 22q11; that abnormality is not necessary for confirming the diagnosis of the DiGeorge syndrome.
After thymus transplantation, circulating T cells developed in increasing numbers in four patients (Patients 1, 2, 3, and 5). In Patients 2, 3, and 5, a substantial response to mitogens was observed on days 27, 28, and 30 after transplantation, respectively; it paralleled the increase in circulating T cells. This time course is similar to that in three reports of fetal thymus transplantation in which T-cell proliferative function increased two days,18 two weeks,16 and one month19 after transplantation. T-cell function in Patient 1 developed more slowly23; normal responses to concanavalin A were detected only after eight months.
TRECs are the episomal circular DNA excision products of T-cell–receptor gene rearrangement. They are not replicated with cell division and are therefore diluted out during proliferation that is associated with antigenic stimulation. Thus, the presence of TRECs in peripheral T cells is thought to be a marker for cells that have recently emigrated from the thymus.39 In Patient 5, we found a temporal correlation among T-cell proliferative function, lymphocyte phenotype, and level of TRECs. In contrast to our finding of an absence of proliferative function, an absence of TRECs, and an absence of CD45RA+CD62L+ T cells before thymus transplantation in Patient 5, six months after transplantation we detected increased proliferative responses to mitogens, increased percentages of CD45RA+CD62L+ T cells, and increased levels of TRECs in both CD4+ cells and CD8+ T cells (Figure 1B). Remarkably, in regard to her normal T-cell function (Table 2), Patient 1 has continued to have CD45RA+CD62L+ T cells and TRECs, suggesting ongoing thymopoiesis (T-cell development in the thymus), more than five years after transplantation.
The T-cell function of many patients with partial DiGeorge syndrome can improve spontaneously,11 but our data argue against spontaneous T-cell improvement in patients with complete DiGeorge syndrome. The TREC levels of Patients 1 and 5 were undetectable in the period immediately before and after transplantation. Patient 5, when tested for the presence of CD45RA+CD62L+ T cells before transplantation, had no detectable cells of this naive phenotype. Lastly, if the patients had had spontaneous improvement, the host T cells would most likely have rejected the allograft. Graft rejection was not found on biopsy of the allograft, however. Thus, we conclude that the reconstitution of T-cell function resulted from transplantation of the thymus tissue.
After transplantation, large numbers of circulating donor T cells were detected in Patient 2, but only small percentages of donor T cells were identified in Patients 3 and 5. No donor cells were detected by fluorescence in situ hybridization in Patient 1. Engraftment of donor T cells after thymus transplantation has not been reported previously in patients with the DiGeorge syndrome.
Although there was at least one full-haplotype mismatch between donor and host in all patients, no graft-versus-host disease or graft rejection was detected at the autopsy in Patients 2 and 3, in the biopsies of the thymic allografts in Patients 1, 3, and 5, or clinically in any of the patients. We estimated that the patients received up to 4×106 donor thymocytes per kilogram with the thymus transplant. In bone marrow transplantation, it is possible to see mild graft-versus-host disease at doses greater than 105 T cells per kilogram.40 We speculate that the absence of graft-versus-host disease in our patients was related to the immaturity of the donor T cells in the thymus grafts. Alternatively, the culture period may have affected T-cell function or resulted in the loss of a subpopulation of cells.
Thymopoiesis is characterized by an ordered pattern of development of T-lineage cells in the thymus. When thymopoiesis is occurring, the evaluation of tissue sections with monoclonal antibodies shows cortical thymocytes coexpressing CD4, CD8, and CD1a and medullary thymocytes expressing either CD4 or CD8 but not CD1a. Immunohistologic evaluation of the thymic-allograft tissue did not reveal thymopoiesis in Patient 2 or Patient 3 but showed normal thymopoiesis in the thymus grafts in Patient 123 and Patient 5. Experiments in animals suggest that major-histocompatibility-complex matching is not necessary for immune reconstitution after transplantation of the thymus.41-48 We continue to attempt partial matching for HLA-DR, because some matching might be helpful. It is not known whether the genetic basis of the thymic aplasia affects the development of thymopoiesis. Neither Patient 1 nor Patient 5 was hemizygous for 22q11. Another factor that may have affected thymopoiesis was the use of steroids. The use of steroids shortly before death in Patients 2 and 3 may have depleted the grafts of developing thymocytes. On the basis of our limited experience, we believe that risk factors for the failure of thymus transplantation include mechanical ventilation, cytomegalovirus infection, and steroid therapy.
Both Patient 1 and Patient 5 had populations of T cells present before transplantation that were oligoclonal on TCRBV analysis, that did not proliferate in response to mitogen stimulation (Table 2 and Table 3 and Figure 1A), and that were not associated with TRECs. Thus, these early increases in oligoclonal T cells did not result from thymopoiesis, which would have produced detectable TRECs, but instead from extrathymic proliferation of preexisting extrathymically differentiated T cells.
Finally, our study shows success in using postnatal thymus tissue for transplantation. The abundance of postnatal thymus tissue as compared with the relative rarity of fetal thymus tissue makes this procedure readily available to children with complete DiGeorge syndrome. We recommend this procedure for patients with complete DiGeorge syndrome who have no T-cell proliferative responses to mitogens.
Supported by grants from the National Institutes of Health (MO1-RR30, U19-AI38550, RO1-CA28936, R21-AI44758, and R21-AG16826); the Max Kade Foundation; and Centeon Pharmaceutics. Dr. Koup is an Elizabeth Glaser Scientist of the Pediatric AIDS Foundation.
We are indebted to Dr. Mark Ballow (Buffalo, N.Y.), Dr. Larry B. Vogler (Atlanta), Dr. Alexander R. Lawton (Nashville), Dr. Charlotte Cunningham-Rundles (New York), and Dr. Talal Chatila (St. Louis) for referral of patients; to Dr. David Lowe for help in caring for Patient 5; to Dr. Ross Ungerleider for assistance in obtaining donor thymus tissues; to T.J. Watson for technical assistance with the preparation of thymic tissue; and to Dr. David Howell, Dr. Pantipa Chatchatee, Paige Jennings, and Natasha Martin for technical help with tissue staining. This paper is dedicated to the family of Patient 3 and is written in memory of the patient's mother, who died seven months after her son.
Source Information
From the Department of Pediatrics, Division of Allergy and Immunology (M.L.M., A.L.K., T.M.M., M.N.B.), the Department of Pathology (L.P.H.), the Department of Immunology (M.L.M., D.D.K., F.E.W.), the Department of Surgery (H.E.R., S.M.M.), and the Duke Comprehensive Cancer Center (M.L.M., L.P.H., D.D.K., F.E.W.), Duke University Medical Center, Durham, N.C.; the Department of Pediatrics, University of Vienna, Vienna, Austria (A.B.); and the Department of Medicine, University of Texas Southwestern Medical Center, Dallas (D.C.D., R.A.K.).
Address reprint requests to Dr. Markert at Box 3068, Duke University Medical Center, Durham, NC 27710, or at marke001@mc.duke.edu.
Other authors were Sherrie E. Schiff, B.S., Miami Children's Hospital, Miami; Rebecca H. Buckley, M.D., Department of Pediatrics, Division of Allergy and Immunology, Department of Immunology, and the Duke Comprehensive Cancer Center, Duke University Medical Center, Durham, N.C.; and Barton F. Haynes, M.D., Department of Immunology and Department of Medicine, Division of Rheumatology, Allergy, and Clinical Immunology, and the Duke Comprehensive Cancer Center, Duke University Medical Center, Durham, N.C.
- References
References
1
Thomas RA ,Landing BH ,Wells TR . Embryologic and other developmental considerations of thirty-eight possible variants of the DiGeorge anomaly. Am J Med Genet Suppl 1987;3:43-66
CrossRef | Medline2
Conley ME ,Beckwith JB ,Mancer JF ,Tenckhoff L . The spectrum of the DiGeorge syndrome. J Pediatr 1979;94:883-890
CrossRef | Web of Science | Medline3
DiGeorge AM. Congenital absence of the thymus and its immunologic consequences: concurrence with congenital hypoparathyroidism. In: Bergsma D, ed. Birth defects original article series. Vol. 4. White Plains, N.Y.: National Foundation March of Dimes, 1968:116.
4
de la Chapelle A ,Herva R ,Koivisto M ,Aula P . A deletion in chromosome 22 can cause DiGeorge syndrome. Hum Genet 1981;57:253-256
Web of Science | Medline5
Driscoll DA ,Salvin J ,Sellinger B , et al. Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counseling and prenatal diagnosis. J Med Genet 1993;30:813-817
CrossRef | Web of Science | Medline6
Daw SC ,Taylor C ,Kraman M , et al. A common region of 10p deleted in DiGeorge and velocardiofacial syndromes. Nat Genet 1996;13:458-460
CrossRef | Web of Science | Medline7
Yamagishi H ,Garg V ,Matsuoka R ,Thomas T ,Srivastava D . A molecular pathway revealing a genetic basis for human cardiac and craniofacial defects. Science 1999;283:1158-1161
CrossRef | Web of Science | Medline8
Hong R . The DiGeorge anomaly: CATCH 22, DiGeorge/velocardiofacial syndrome. Semin Hematol 1998;35:282-290
Web of Science | Medline9
Muller W ,Peter HH ,Wilken M , et al. The DiGeorge syndrome. I. Clinical evaluation and course of partial and complete forms of the syndrome. Eur J Pediatr 1988;147:496-502
CrossRef | Web of Science | Medline10
Muller W ,Peter HH ,Kallfelz HC ,Franz A ,Rieger CH . The DiGeorge sequence. II. Immunologic findings in partial and complete forms of the disorder. Eur J Pediatr 1989;149:96-103
CrossRef | Web of Science | Medline11
Bastian J ,Law S ,Vogler L , et al. Prediction of persistent immunodeficiency in the DiGeorge anomaly. J Pediatr 1989;115:391-396
CrossRef | Web of Science | Medline12
Markert ML ,Hummell DS ,Rosenblatt HM , et al. Complete DiGeorge syndrome: persistence of profound immunodeficiency. J Pediatr 1998;132:15-21
CrossRef | Web of Science | Medline13
Goldsobel AB ,Haas A ,Stiehm ER . Bone marrow transplantation in DiGeorge syndrome. J Pediatr 1987;111:40-44
CrossRef | Web of Science | Medline14
Borzy MS ,Ridgway D ,Noya FJ ,Shearer WT . Successful bone marrow transplantation with split lymphoid chimerism in DiGeorge syndrome. J Clin Immunol 1989;9:386-392
CrossRef | Web of Science | Medline15
Bowers DC ,Lederman HM ,Sicherer SH ,Winkelstein JA ,Chen AR . Immune reconstitution of complete DiGeorge anomaly by transplantation of unmobilized blood mononuclear cells. Lancet 1998;352:1983-1984
CrossRef | Web of Science | Medline16
August CS ,Berkel AI ,Levey RH ,Rosen FS ,Kay HE . Establishment of immunological competence in a child with congenital thymic aplasia by a graft of fetal thymus. Lancet 1970;1:1080-1083
CrossRef | Web of Science | Medline17
Cleveland WW ,Fogel BJ ,Brown WT ,Kay HE . Foetal thymic transplant in a case of DiGeorge's syndrome. Lancet 1968;2:1211-1214
CrossRef | Web of Science | Medline18
Jose DG ,Barnes G ,Rossiter EJ ,Myers NA ,Fitzgerald MG . Reconstitution of cellular immune function in a child with thymic aplasia by foetal thymus grafting. Aust N Z J Med 1974;4:267-273
CrossRef | Medline19
Mayumi M ,Kimata H ,Suehiro Y , et al. DiGeorge syndrome with hypogammaglobulinaemia: a patient with excess suppressor T cell activity treated with fetal thymus transplantation. Eur J Pediatr 1989;148:518-522
CrossRef | Web of Science | Medline20
Reece ER ,Gartner JG ,Seemayer TA ,Joncas JH ,Pagano JS . Epstein-Barr virus in a malignant lymphoproliferative disorder of B-cells occurring after thymic epithelial transplantation for combined immunodeficiency. Cancer Res 1981;41:4243-4247
Web of Science | Medline21
Dictor M ,Fasth A ,Olling S . Abnormal B-cell proliferation associated with combined immunodeficiency, cytomegalovirus, and cultured thymus grafts. Am J Clin Pathol 1984;82:487-490
Web of Science | Medline22
Borzy MS ,Hong R ,Horowitz SD , et al. Fatal lymphoma after transplantation of cultured thymus in children with combined immunodeficiency disease. N Engl J Med 1979;301:565-568
Full Text | Web of Science | Medline23
Markert ML ,Kostyu DD ,Ward FE , et al. Successful formation of a chimeric human thymus allograft following transplantation of cultured postnatal human thymus. J Immunol 1997;158:998-1005
Web of Science | Medline24
Hong R ,Moore AL . Organ culture for thymus transplantation. Transplantation 1996;61:444-448
CrossRef | Web of Science | Medline25
Markert ML ,Watson TJ ,Kaplan I ,Hale LP ,Haynes BF . The human thymic microenvironment during organ culture. Clin Immunol Immunopathol 1997;82:26-36
CrossRef | Medline26
Buckley RH ,Schiff SE ,Sampson HA , et al. Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation. J Immunol 1986;136:2398-2407
Web of Science | Medline27
Olerup O ,Zetterquist H . HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992;39:225-235
CrossRef | Web of Science | Medline28
Kostyu DD ,Pfohl J ,Ward FE ,Lee J ,Murray A ,Amos DB . Rapid HLA-DR oligotyping by an enzyme-linked immunosorbent assay performed in microtiter trays. Hum Immunol 1993;38:148-158
CrossRef | Web of Science | Medline29
Douek DC ,McFarland RD ,Keiser PH , et al. Changes in thymic function with age and during the treatment of HIV infection. Nature 1998;396:690-695
CrossRef | Web of Science | Medline30
Davis CM ,McLaughlin TM ,Watson TJ , et al. Normalization of the peripheral blood T cell receptor Vβ repertoire after cultured postnatal human thymic transplantation in DiGeorge syndrome. J Clin Immunol 1997;17:167-175
CrossRef | Web of Science | Medline31
Wells TR ,Gilsanz V ,Senac MO Jr ,Landing BH ,Vachon L ,Takahashi M . Ossification centre of the hyoid bone in DiGeorge syndrome and tetralogy of Fallot. Br J Radiol 1986;59:1065-1068
CrossRef | Web of Science | Medline32
Erkeller-Yuksel FM ,Deneys V ,Yuksel B , et al. Age-related changes in human blood lymphocyte subpopulations. J Pediatr 1992;120:216-222
CrossRef | Web of Science | Medline33
Markert ML ,Majure M ,Harville TO ,Hulka G ,Oldham KO . Severe laryngomalacia and bronchomalacia in DiGeorge syndrome and CHARGE association. Pediatr Pulmonol 1997;24:364-369
CrossRef | Web of Science | Medline34
Davenport SL ,Hefner MA ,Mitchell JA . The spectrum of clinical features in CHARGE syndrome. Clin Genet 1986;29:298-310
CrossRef | Web of Science | Medline35
Pagon RA ,Graham JM Jr ,Zonana J ,Yong SL . Coloboma, congenital heart disease, and choanal atresia with multiple anomalies: CHARGE association. J Pediatr 1981;99:223-227
CrossRef | Web of Science | Medline36
Metlay LA ,Smythe PS ,Miller ME . Familial CHARGE syndrome: clinical report with autopsy findings. Am J Med Genet 1987;26:577-581
CrossRef | Web of Science | Medline37
Hong R . Reconstitution of T-cell deficiency by thymic hormone or thymus transplantation therapy. Clin Immunol Immunopathol 1986;40:136-141
CrossRef | Medline38
Jenkinson EJ ,Franchi LL ,Kingston R ,Owen JJ . Effect of deoxyguanosine on lymphopoiesis in the developing thymus rudiment in vitro: application in the production of chimeric thymus rudiments. Eur J Immunol 1982;12:583-587
CrossRef | Web of Science | Medline39
Kong FK ,Chen CLH ,Six A ,Hockett RD ,Cooper MD . T cell receptor gene deletion circles identify recent thymic emigrants in the peripheral T cell pool. Proc Natl Acad Sci U S A 1999;96:1536-1540
CrossRef | Web of Science | Medline40
Kernan NA ,Collins NH ,Juliano L ,Cartagena T ,Dupont B ,O'Reilly RJ . Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease. Blood 1986;68:770-773
Web of Science | Medline41
Zinkernagel RM ,Althage A ,Waterfield E , et al. Restriction specificities, alloreactivity, and allotolerance expressed by T cells from nude mice reconstituted with H-2-compatible or -incompatible thymus grafts. J Exp Med 1980;151:376-399
CrossRef | Web of Science | Medline42
Lake JP ,Andrew ME ,Pierce CW ,Braciale TJ . Sendai virus-specific, H2-restricted cytotoxic T lymphocyte responses of nude mice grafted with allogenic or semi-allogenic thymus glands. J Exp Med 1980;152:1805-1810
CrossRef | Web of Science | Medline43
Kruisbeek AM ,Sharrow SO ,Mathieson BJ ,Singer A . The H-2 phenotype of the thymus dictates the self-specificity expressed by thymic but not splenic cytotoxic T lymphocyte precursors in thymus-engrafted nude mice. J Immunol 1981;127:2168-2176
Web of Science | Medline44
Kast WM ,de Waal LP ,Melief CJ . Thymus dictates major histocompatibility complex (MHC) specificity and immune response gene phenotype of class II MHC-restricted T cells but not of class I MHC-restricted T cells. J Exp Med 1984;160:1752-1766
CrossRef | Web of Science | Medline45
Longo DL ,Kruisbeek AM ,Davis ML ,Matis LA . Bone marrow-derived thymic antigen-presenting cells determine self-recognition of Ia-restricted T lymphocytes. Proc Natl Acad Sci U S A 1985;82:5900-5904
CrossRef | Web of Science | Medline46
Benoist C ,Mathis D . Positive selection of the T cell repertoire: where and when does it occur? Cell 1989;58:1027-1033
CrossRef | Web of Science | Medline47
Hong R ,Schulte-Wissermann H ,Jarrett-Toth E ,Horowitz SD ,Manning DD . Transplantation of cultured thymic fragments. II. Results in nude mice. J Exp Med 1979;149:398-415
CrossRef | Web of Science | Medline48
Zhao Y ,Fishman JA ,Sergio JJ , et al. Immune restoration by fetal pig thymus grafts in T cell-depleted, thymectomized mice. J Immunol 1997;158:1641-1649
Web of Science | Medline
- Citing Articles (103)
Citing Articles
1
I. K. Chinn, J. D. Milner, P. Scheinberg, D. C. Douek, M. L. Markert. (2013) Thymus transplantation restores the repertoires of forkhead box protein 3 (FoxP3) + and FoxP3 − T cells in complete DiGeorge anomaly. Clinical & Experimental Immunology 173:1, 140-149
2
Pierre Olivier Lang, Sheila Govind, Richard Aspinall. (2013) Reversing T cell immunosenescence: why, who, and how. AGE 35:3, 609-620
3
Rochelle Hirschhorn, Kurt Hirschhorn, Luigi D. Notarangelo. Immunodeficiency Disorders. In: Emery and Rimoin's Principles and Practice of Medical Genetics. Elsevier, 2013:1-30.
4
Naoki Hosaka. (2013) New Allogeneic Hematopoietic Stem Cell Transplantation Method: Hematopoietic Stem Cell Transplantation Plus Thymus Transplantation for Intractable Diseases. Clinical and Developmental Immunology 2013, 1-7
5
Junji Komori, Lindsey Boone, Aaron DeWard, Toshitaka Hoppo, Eric Lagasse. (2012) The mouse lymph node as an ectopic transplantation site for multiple tissues. Nature Biotechnology 30:10, 976-983
6
Yuming Zhang, Naoki Hosaka, Yunze Cui, Ming Shi, Ming Li, Qing Li, Susumu Ikehara. (2012) Effects of Intrabone Marrow–Bone Marrow Transplantation Plus Adult Thymus Transplantation on Survival of Mice Bearing Leukemia. Stem Cells and Development 21:9, 1441-1448
7
Susan McClory, Tiffany Hughes, Aharon G. Freud, Edward L. Briercheck, Chelsea Martin, Anthony J. Trimboli, Jianhua Yu, Xiaoli Zhang, Gustavo Leone, Gerard Nuovo, Michael A. Caligiuri. (2012) Evidence for a stepwise program of extrathymic T cell development within the human tonsil. Journal of Clinical Investigation
8
A. R. Gennery. (2011) Immunological aspects of 22q11.2 deletion syndrome. Cellular and Molecular Life Sciences
9
Shang-xue Yan, Wei Wei. (2011) Castration reverses immunosenescence in aged mice. Acta Pharmacologica Sinica 32:9, 1085-1086
10
Bin Li, Jie Li, Blythe H. Devlin, M. Louise Markert. (2011) Thymic microenvironment reconstitution after postnatal human thymus transplantation. Clinical Immunology 140:3, 244-259
11
Abbas F. Jawad, Eline Luning Prak, Jean Boyer, Donna M. McDonald-McGinn, Elaine Zackai, Kenyetta McDonald, Kathleen E. Sullivan. (2011) A Prospective Study of Influenza Vaccination and a Comparison of Immunologic Parameters in Children and Adults with Chromosome 22q11.2 Deletion Syndrome (DiGeorge Syndrome/Velocardiofacial Syndrome). Journal of Clinical Immunology
12
Britte C. Beaudette-Zlatanova, Katherine L. Knight, Shubin Zhang, Patrick J. Stiff, Juan Carlos Zúñiga-Pflücker, Phong T. Le. (2011) A human thymic epithelial cell culture system for the promotion of lymphopoiesis from hematopoietic stem cells. Experimental Hematology 39:5, 570-579
13
Yuming Zhang, Naoki Hosaka, Yunze Cui, Ming Shi, Susumu Ikehara. (2011) Effects of Allogeneic Hematopoietic Stem Cell Transplantation Plus Thymus Transplantation on Malignant Tumors: Comparison Between Fetal, Newborn, and Adult Mice. Stem Cells and Development 20:4, 599-607
14
Michael D Green, Hans-Willem Snoeck. (2011) Novel approaches for immune reconstitution and adaptive immune modeling with human pluripotent stem cells. BMC Medicine 9:1, 51
15
Naoki Hosaka, Wenhao Cui, Yuming Zhang, Takashi Takaki, Muneo Inaba, Susumu Ikehara. (2010) Prolonged survival in mice with advanced tumors treated with syngeneic or allogeneic intra-bone marrow–bone marrow transplantation plus fetal thymus transplantation. Cancer Immunology, Immunotherapy 59:7, 1121-1130
16
M. Louise Markert, Blythe H. Devlin, Elizabeth A. McCarthy. (2010) Thymus transplantation. Clinical Immunology 135:2, 236-246
17
Alain Fischer. The Immunocompromised Host. In: Topley & Wilson's Microbiology and Microbial Infections. John Wiley & Sons, Ltd, 2010.
18
J. Ongrádi, B. Stercz, Valéria Kövesdi, L. Vértes. (2009) Immunosenescence and vaccination of the elderly II. New strategies to restore age-related immune impairment. Acta Microbiologica et Immunologica Hungarica 56:4, 301-312
19
Sean A. McGhee, Maria Garcia Lloret, E. Richard Stiehm. (2009) Immunologic reconstitution in 22q deletion (DiGeorge) syndrome. Immunologic Research 45:1, 37-45
20
Ricardo Pujol-Borrell, Maria Jose Herrero-Mata, Eduard Palou, Maria Pilar Armengol. (2009) Immunological Senescence and Thymic Function in Transplantation. Transplantation 88:Supplement, S8-S13
21
Bin Li, Jie Li, Chia-San Hsieh, Laura P. Hale, Yi-Ju Li, Blythe H. Devlin, M. Louise Markert. (2009) Characterization of cultured thymus tissue used for transplantation with emphasis on promiscuous expression of thyroid tissue-specific genes. Immunologic Research 44:1-3, 71-83
22
T Nishida, N Hosaka, T Takaki, T Miyake, W Cui, M Inaba, H Kinoshita, T Matsuda, S Ikehara. (2009) Allogeneic intra-BM-BMT plus adult thymus transplantation from same donor has benefits for long-term survival even after sublethal irradiation or low-dose BM cell injection. Bone Marrow Transplantation 43:11, 829-837
23
Takashi Miyake, Naoki Hosaka, Wenhao Cui, Teruhisa Nishida, Takashi Takaki, Muneo Inaba, Yasuo Kamiyama, Susumu Ikehara. (2009) Adult thymus transplantation with allogeneic intra-bone marrow-bone marrow transplantation from same donor induces high thymopoiesis, mild graft-versus-host reaction and strong graft-versus-tumour effects. Immunology 126:4, 552-564
24
Andreas H. Groll, Emmanuel Roilides, Thomas J. Walsh. Fungal infections in pediatric patients. In: Clinical Mycology. Elsevier, 2009:481-499.
25
Werner Krenger, Georg A. Holländer. (2008) The immunopathology of thymic GVHD. Seminars in Immunopathology 30:4, 439-456
26
E. Mancebo, J. Clemente, J. Sanchez, J. Ruiz-Contreras, P. De Pablos, S. Cortezon, E. Romo, E. Paz-Artal, L. M. Allende. (2008) Longitudinal analysis of immune function in the first 3 years of life in thymectomized neonates during cardiac surgery. Clinical & Experimental Immunology 154:3, 375-383
27
Kyeong Deok Lee, Tadaharu Okazaki, Yoshifumi Kato, Geoffrey J. Lane, Atsuyuki Yamataka. (2008) Esophageal atresia and tracheo-esophageal fistula associated with coarctation of the aorta, CHARGE association, and DiGeorge syndrome: a case report and literature review. Pediatric Surgery International 24:10, 1153-1156
28
T Ryu, N Hosaka, T Miyake, W Cui, T Nishida, T Takaki, M Li, K Kawamoto, S Ikehara. (2008) Transplantation of newborn thymus plus hematopoietic stem cells can rescue supralethally irradiated mice. Bone Marrow Transplantation 41:7, 659-666
29
Maria Angelica Selim, Mary L. Markert, James L. Burchette, Christopher M. Herman, John W. Turner. (2008) The cutaneous manifestations of atypical complete DiGeorge syndrome: a histopathologic and immunohistochemical study. Journal of Cutaneous Pathology 35:4, 380-385
30
Wenhao Cui, Naoki Hosaka, Takashi Miyake, Xiaoli Wang, Kequan Guo, Yunze Cui, Qiang Li, Changye Song, Wei Feng, Qing Li, Takashi Takaki, Teruhisa Nishida, Muneo Inaba, Susumu Ikehara. (2008) Analysis of Tolerance Induction Using Triple Chimeric Mice: Major Histocompatibility Complex-Disparate Thymus, Hemopoietic Cells, and Microenvironment. Transplantation 85:8, 1151-1158
31
Ivan K. Chinn, Blythe H. Devlin, Yi-Ju Li, M. Louise Markert. (2008) Long-term tolerance to allogeneic thymus transplants in complete DiGeorge anomaly. Clinical Immunology 126:3, 277-281
32
ALLEN W. ROOT, FRANK B. DIAMOND. Disorders of Mineral Homeostasis in the Newborn, Infant, Child, and Adolescent. In: Pediatric Endocrinology. Elsevier, 2008:686-769.
33
J.C. Rückert, M. Ismail, M. Swierzy, C. Braumann, H. Badakhshi, P. Rogalla, A. Meisel, R.I. Rückert, J.M. Müller. (2008) Minimal-invasive Chirurgie des Thymus. Der Chirurg 79:1, 18-25
34
Natalie Seach, Daniel Layton, Joanna Lim, Ann Chidgey, Richard Boyd. (2007) Thymic generation and regeneration: a new paradigm for establishing clinical tolerance of stem cell-based therapies. Current Opinion in Biotechnology 18:5, 441-447
35
Michael H. Land, Maria I. Garcia-Lloret, Michael S. Borzy, P. Nagesh Rao, Najib Aziz, Sean A. McGhee, Karin Chen, Jack Gorski, E. Richard Stiehm. (2007) Long-term results of bone marrow transplantation in complete DiGeorge syndrome. Journal of Allergy and Clinical Immunology 120:4, 908-915
36
Lisa J Kobrynski, Kathleen E Sullivan. (2007) Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. The Lancet 370:9596, 1443-1452
37
L HUDSON, M LOUISEMARKERT, B DEVLIN, B HAYNES, G SEMPOWSKI. (2007) Human T cell reconstitution in DiGeorge syndrome and HIV-1 infection. Seminars in Immunology 19:5, 297-309
38
Madhurima Sanka, Nutthapong Tangsinmankong, Melissa Loscalzo, John W. Sleasman, Morna J. Dorsey. (2007) Complete DiGeorge syndrome associated with CHD7 mutation. Journal of Allergy and Clinical Immunology 120:4, 952-954
39
Karin Writzl, Catherine M. Cale, Christine M. Pierce, Louise C. Wilson, Raoul C.M. Hennekam. (2007) Immunological abnormalities in CHARGE syndrome. European Journal of Medical Genetics 50:5, 338-345
40
Beverly N. Hay. (2007) Deletion 22q11: Spectrum of Associated Disorders. Seminars in Pediatric Neurology 14:3, 136-139
41
M. Sykes. (2007) Immune tolerance: mechanisms and application in clinical transplantation. Journal of Internal Medicine 262:3, 288-310
42
M Jiménez, G Ercilla, C Martínez. (2007) Immune reconstitution after allogeneic stem cell transplantation with reduced-intensity conditioning regimens. Leukemia 21:8, 1628-1637
43
Danielle Aw, Alberto B. Silva, Donald B. Palmer. (2007) Immunosenescence: emerging challenges for an ageing population. Immunology 120:4, 435-446
44
N. Hosaka, T. Ryu, T. Miyake, W. Cui, T. Nishida, T. Takaki, M. Inaba, S. Ikehara. (2007) Treatment of autoimmune diseases in MRL/lpr mice by allogenic bone marrow transplantation plus adult thymus transplantation. Clinical & Experimental Immunology 147:3, 555-563
45
Tamas Fülöp, Anis Larbi, Katsuiku Hirokawa, Eugenio Mocchegiani, Bruno Lesourd, Stephen Castle, Anders Wikby, Claudio Franceschi, Graham Pawelec. (2007) Immunosupportive therapies in aging. Clinical Interventions in Aging 2:1, 33-54
46
Jerry A. Winkelstein. Primary Immunodeficiency Diseases. In: Comprehensive Pediatric Hospital Medicine. Elsevier, 2007:864-869.
47
T. A. Fleisher. (2006) Back to Basics: Primary Immune Deficiencies: Windows into the Immune System. Pediatrics in Review 27:10, 363-372
48
Lisa J. Kobrynski. (2006) Combined Immune Deficiencies in Children. Journal of Infusion Nursing 29:4, 206-213
49
Tahsin Yakut, Sara Sebnem Kilic, Ergun Cil, Esra Yapici, Unal Egeli. (2006) FISH investigation of 22q11.2 deletion in patients with immunodeficiency and/or cardiac abnormalities. Pediatric Surgery International 22:4, 380-383
50
José-Ignacio Rodríguez-Barbosa, Gary W. Haller, Guiling Zhao, David H. Sachs, Megan Sykes. (2005) Host thymectomy and cyclosporine lead to unstable skin graft tolerance after class I mismatched allogeneic neonatal thymic transplantation in mice. Transplant Immunology 15:1, 25-33
51
Mónica Jiménez, Carmen Martínez, Guadalupe Ercilla, Enric Carreras, Álvaro Urbano-Ispízua, Marta Aymerich, Neus Villamor, Nuria Amézaga, Montserrat Rovira, Francesc Fernández-Avilés, Anna Gaya, Rodrigo Martino, Jorge Sierra, Emili Montserrat. (2005) Reduced-intensity conditioning regimen preserves thymic function in the early period after hematopoietic stem cell transplantation. Experimental Hematology 33:10, 1240-1248
52
Alan P. Knutsen. (2005) Conventional Treatment of Primary Immunodeficiency Disorders. Pediatric Asthma, Allergy & Immunology 18:3, 140-155
53
Julie Y. Patel, David P. Huston. (2005) Thymus transplantation advances in DiGeorge syndrome. Current Allergy and Asthma Reports 5:5, 348-349
54
Michael I. Luster, Victor J. Johnson, Berran Yucesoy, Petia P. Simeonova. (2005) Biomarkers to assess potential developmental immunotoxicity in children. Toxicology and Applied Pharmacology 206:2, 229-236
55
Francisco A. Bonilla, I. Leonard Bernstein, David A. Khan, Zuhair K. Ballas, Javier Chinen, Michael M. Frank, Lisa J. Kobrynski, Arnold I. Levinson, Bruce Mazer, Robert P. Nelson, Jordan S. Orange, John M. Routes, William T. Shearer, Ricardo U. Sorensen. (2005) Practice parameter for the diagnosis and management of primary immunodeficiency. Annals of Allergy, Asthma & Immunology 94:5, S1-S63
56
Caterina Cancrini, Maria Luisa Romiti, Andrea Finocchi, Silvia Di Cesare, Patrizia Ciaffi, Claudia Capponi, Savita Pahwa, Paolo Rossi. (2005) Post-Natal Ontogenesis of the T-Cell Receptor CD4 and CD8 Vβ Repertoire and Immune Function in Children with DiGeorge Syndrome. Journal of Clinical Immunology 25:3, 265-274
57
Caroline L. Hollingsworth. (2005) Thoracic Disorders in the Immunocompromised Child. Radiologic Clinics of North America 43:2, 435-447
58
Evert-Jan Wils, Jan J. Cornelissen. (2005) Thymopoiesis following allogeneic stem cell transplantation: new possibilities for improvement. Blood Reviews 19:2, 89-98
59
Matthias Eyrich, Gernot Wollny, Nikolaj Tzaribaschev, Klaus Dietz, Dorothee Brügger, Peter Bader, Peter Lang, Karin Schilbach, Beate Winkler, Dietrich Niethammer, Paul G. Schlegel. (2005) Onset of thymic recovery and plateau of thymic output are differentially regulated after stem cell transplantation in children. Biology of Blood and Marrow Transplantation 11:3, 194-205
60
Marcel R. M. van den Brink, Önder Alpdogan, Richard L. Boyd. (2004) Strategies to enhance T-cell reconstitution in immunocompromised patients. Nature Reviews Immunology 4:11, 856-867
61
Thomas A. Fleisher, João Bosco Oliveira. (2004) Functional and molecular evaluation of lymphocytes. Journal of Allergy and Clinical Immunology 114:2, 227-234
62
C. Clare Blackburn, Nancy R. Manley. (2004) Developing a new paradigm for thymus organogenesis. Nature Reviews Immunology 4:4, 278-289
63
M Louise Markert, Marilyn J Alexieff, Jie Li, Marcella Sarzotti, Daniel A Ozaki, Blythe H Devlin, Gregory D Sempowski, Maria E Rhein, Paul Szabolcs, Laura P Hale, Rebecca H Buckley, Katharine E Coyne, Henry E Rice, Samuel M Mahaffey, Michael A Skinner. (2004) Complete DiGeorge syndrome: Development of rash, lymphadenopathy, and oligoclonal T cells in 5 cases. Journal of Allergy and Clinical Immunology 113:4, 734-741
64
Rebecca H Buckley. (2004) A historical review of bone marrow transplantation for immunodeficiencies. Journal of Allergy and Clinical Immunology 113:4, 793-800
65
Anil Shanker. (2004) Is thymus redundant after adulthood?. Immunology Letters 91:2-3, 79-86
66
Rebecca H. Buckley. (2004) Pulmonary complications of primary immunodeficiencies. Paediatric Respiratory Reviews 5, S225-S233
67
Richard Aspinall. (2003) Age-related changes in the function of T cells. Microscopy Research and Technique 62:6, 508-513
68
D. G. HAEGERT, D. GALUTIRA, T. J. MURRAY, P. O'CONNOR, V. GADAG. (2003) Identical twins discordant for multiple sclerosis have a shift in their T-cell receptor repertoires. Clinical and Experimental Immunology 134:3, 532-537
69
Steven J Simonte, Charlotte Cunningham-Rundles. (2003) Update on primary immunodeficiency: defects of lymphocytes. Clinical Immunology 109:2, 109-118
70
Jason Gill, Mark Malin, Jayne Sutherland, Daniel Gray, George Hollander, Richard Boyd. (2003) Thymic generation and regeneration. Immunological Reviews 195:1, 28-50
71
Mirija Svaldi, Andrea Judith Lanthaler, Martin Dugas, Peter Lohse, Norbert Pescosta, Christian Straka, Manfred Mitterer. (2003) T-cell receptor excision circles: a novel prognostic parameter for the outcome of transplantation in multiple myeloma patients. British Journal of Haematology 122:5, 795-801
72
M. PIERDOMINICI, F. MAZZETTA, E. CAPRINI, M. MARZIALI, M. C. DIGILIO, B. MARINO, A. AIUTI, F. AMATI, G. RUSSO, G. NOVELLI, F. PANDOLFI, G. LUZI, A. GIOVANNETTI. (2003) Biased T-cell receptor repertoires in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Clinical and Experimental Immunology 132:2, 323-331
73
S Pirovano, E Mazzolari, S Pasic, A Albertini, Luigi D Notarangelo, L Imberti. (2003) Impaired thymic output and restricted T-cell repertoire in two infants with immunodeficiency and early-onset generalized dermatitis. Immunology Letters 86:1, 93-97
74
Javier Chinen, Howard M. Rosenblatt, E.O'Brian Smith, William T. Shearer, Lenora M. Noroski. (2003) Long-term assessment of T-cell populations in DiGeorge syndrome. Journal of Allergy and Clinical Immunology 111:3, 573-579
75
F BONILLA. (2003) 12. Primary immunodeficiency diseases. Journal of Allergy and Clinical Immunology 111:2, 571-581
76
R BUCKLEY. (2003) 27. Transplantation immunology: Organ and bone marrow. Journal of Allergy and Clinical Immunology 111:2, 733-744
77
Ricardo Pujol Borrell, Lidia Sabater Baudet. (2003) El timo: vieja glándula, nuevas ideas. Medicina Clínica 120:6, 216-218
78
Elena Perez, Kathleen E. Sullivan. (2002) Chromosome 22q11.2 deletion syndrome (DiGeorge and velocardiofacial syndromes). Current Opinion in Pediatrics 14:6, 678-683
79
Frances T. Hakim, Ronald E. Gress. (2002) Reconstitution of thymic function after stem cell transplantation in humans. Current Opinion in Hematology 9:6, 490-496
80
Stuart P Berzins, Adam P Uldrich, Jayne S Sutherland, Jason Gill, Jacques F.A.P Miller, Dale I Godfrey, Richard L Boyd. (2002) Thymic regeneration: teaching an old immune system new tricks. Trends in Molecular Medicine 8:10, 469-476
81
V. GUAZZI, F. AIUTI, I. MEZZAROMA, F. MAZZETTA, G. ANDOLFI, A. Mortellaro, M. Pierdominici, R. FANTINI, M. MARZIALI, A. AIUTI. (2002) Assessment of thymic output in common variable immunodeficiency patients by evaluation of T cell receptor excision circles. Clinical & Experimental Immunology 129:2, 346-353
82
C.Clare Blackburn, Nancy R. Manley, Donald B. Palmer, Richard L. Boyd, Graham Anderson, Mary A. Ritter. (2002) One for all and all for one: thymic epithelial stem cells and regeneration. Trends in Immunology 23:8, 391-395
83
Max D. Cooper. (2002) Exploring lymphocyte differentiation pathways. Immunological Reviews 185:1, 175-185
84
Robert A. Good. (2002) Cellular immunology in a historical perspective. Immunological Reviews 185:1, 136-158
85
Andrea R. Bennett, Alison Farley, Natalie F. Blair, Julie Gordon, Linda Sharp, C.Clare Blackburn. (2002) Identification and Characterization of Thymic Epithelial Progenitor Cells. Immunity 16:6, 803-814
86
Danièle Bensoussan, Françoise Le Deist, Véronique Latger-Cannard, Marie José Grégoire, Odile Avinens, Pierre Feugier, Violaine Bourdon, Christine André-Botté, Claudine Schmitt, Philippe Jonveaux, Jean François Eliaou, Jean François Stoltz, Pierre Bordigoni. (2002) T-cell immune constitution after peripheral blood mononuclear cell transplantation in complete DiGeorge syndrome. British Journal of Haematology 117:4, 899-906
87
Rebecca H. Buckley. (2002) Primary cellular immunodeficiencies. Journal of Allergy and Clinical Immunology 109:5, 747-757
88
Gregory D. Sempowski, Maria E. Gooding, H.X. Liao, Phong T. Le, Barton F. Haynes. (2002) T cell receptor excision circle assessment of thymopoiesis in aging mice. Molecular Immunology 38:11, 841-848
89
Gregory D. Sempowski, Barton F. Haynes. (2002) I
MMUNE RECONSTITUTION IN PATIENTS WITH HIV INFECTION . Annual Review of Medicine 53:1, 269-28490
Jeffrey Pido-Lopez, Richard Aspinall. Effective immunity during late life; a possible role for the thymus. Elsevier, 2002:79-91.
91
Debbie Fraser Askin, Sandra Young. (2001) The Thymus Gland. Neonatal Network: The Journal of Neonatal Nursing 20:8, 7-13
92
M. Louise Markert, Africa P. Alvarez-Mcleod, Gregory D. Sempowski, Laura P. Hale, Joseph M. Horvatinovich, Kent J. Weinhold, John A. Bartlett, Thomas A. D'Amico, Barton F. Haynes. (2001) Thymopoiesis in HIV-Infected Adults after Highly Active Antiretroviral Therapy. AIDS Research and Human Retroviruses 17:17, 1635-1643
93
Kathleen E. Sullivan. (2001) Digeorge syndrome/chromosome 22q11.2 deletion syndrome. Current Allergy and Asthma Reports 1:5, 438-444
94
Matthias Eyrich, Peter Lang, Shangara Lal, Peter Bader, Rupert Handgretinger, Thomas Klingebiel, Dietrich Niethammer, Paul G. Schlegel. (2001) A prospective analysis of the pattern of immune reconstitution in a paediatric cohort following transplantation of positively selected human leucocyte antigen-disparate haematopoietic stem cells from parental donors. British Journal of Haematology 114:2, 422-432
95
Richard Hong, Violet Shen, Cliona Rooney, Dennis P.M. Hughes, Colton Smith, Patricia Comoli, Linqi Zhang. (2001) Correction of DiGeorge Anomaly with EBV-Induced Lymphoma by Transplantation of Organ-Cultured Thymus and Epstein–Barr-Specific Cytotoxic T Lymphocytes. Clinical Immunology 98:1, 54-61
96
Marx , Stephen J. , . (2000) Hyperparathyroid and Hypoparathyroid Disorders. New England Journal of Medicine 343:25, 1863-1875
Full Text97
Carolyn M. Steffens, Lena Al-Harthi, Susan Shott, Ram Yogev, Alan Landay. (2000) Evaluation of Thymopoiesis Using T Cell Receptor Excision Circles (TRECs): Differential Correlation between Adult and Pediatric TRECs and Naı̈ve Phenotypes. Clinical Immunology 97:2, 95-101
98
M. Pierdominici, M. Marziali, A. Giovannetti, A. Oliva, R. Rosso, B. Marino, M. C. Digilio, A. Giannotti, G. Novelli, B. Dallapiccola, F. Aiuti, F. Pandolfi. (2000) T cell receptor repertoire and function in patients with DiGeorge syndrome and velocardiofacial syndrome. Clinical and Experimental Immunology 121:1, 127-132
99
Patel , Dhavalkumar D. , Gooding , Maria E. , Parrott , Roberta E. , Curtis , Kimberly M. , Haynes , Barton F. , Buckley , Rebecca H. , . (2000) Thymic Function after Hematopoietic Stem-Cell Transplantation for the Treatment of Severe Combined Immunodeficiency. New England Journal of Medicine 342:18, 1325-1332
Free Full Text100
Daniel C Douek, Robert A Vescio, Michael R Betts, Jason M Brenchley, Brenna J Hill, Lan Zhang, James R Berenson, Robert H Collins, Richard A Koup. (2000) Assessment of thymic output in adults after haematopoietic stemcell transplantation and prediction of T-cell reconstitution. The Lancet 355:9218, 1875-1881
101
Barton F. Haynes, M. Louise Markert, Gregory D. Sempowski, Dhavalkumar D. Patel, Laura P. Hale. (2000) The Role of the Thymus in Immune Reconstitution in Aging, Bone Marrow Transplantation, and HIV-1 Infection. Annual Review of Immunology 18:1, 529-560
102
M. Louise Markert, Charles B. Hicks, John A. Bartlett, J. Les Harmon, Laura P. Hale, Michael L. Greenberg, Guido Ferrari, Janet Ottinger, Andreas Boeck, Amy L. Kloster, Tanya M. M, Laughlin, Karen B. Bleich, Ross M. Ungerleider, H. Kim Lyerly, William E. Wilkinson, Franck S. Rousseau, M Argo E. Heath-Chiozzi, John M. Leonard, Ashley T. Haase, George M ., R. Pat Bucy, Daniel C. Douek, Richard A. Koup, Barton F. Haynes, Dani P. Bolognesi, Kent J. Weinhold. (2000) Effect of Highly Active Antiretroviral Therapy and Thymic Transplantation on Immunoreconstitution in HIV Infection. AIDS Research and Human Retroviruses 16:5, 403-413
103
Weissman , Irving L. , Shizuru , Judith A. , . (1999) Immune Reconstitution. New England Journal of Medicine 341:16, 1227-1229
Full Text
